GlassScriptPhysician profile
Jill A Taylor
NPI 1912012832
$4,589.00
in general payments reported to CMS, 2019-2025
41 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $722 · 2020: $730 · 2021: $932 · 2022: $629 · 2023: $870 · 2024: $275 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,575.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $693.65 | 2019-2024 | Trelegy Ellipta |
| Novo Nordisk INC | $613.99 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $402.36 | 2019-2025 | Breztri, Airsupra |
| Lilly USA, LLC | $399.08 | 2020-2025 | Jardiance, Zepbound |
| Abbvie INC. | $322.38 | 2021-2024 | Vraylar, Ubrelvy |
| Abbott Laboratories | $216.72 | 2021-2024 | Freestyle Libre 3, Proclaim |
| Biohaven Pharmaceutical Holding Company LTD. | $165.53 | 2022 | |
| Azurity Pharmaceuticals, INC. | $156.37 | 2023-2024 | Horizant, Horizant, Edarbi |
| Allergan, INC. | $155.40 | 2020 | |
| Arbor Pharmaceuticals, INC. | $152.66 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $127.62 | 2020 | |
| Exact Sciences Corporation | $94.09 | 2023-2025 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $82.81 | 2023 | Quviviq |
| Adlon Therapeutics L.P. | $79.66 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $77.86 | 2023 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.